semaglutide and sjogren's VisualAbstract: Ianalumab shows a dose-related improvement in disease activity in Sjögren's syndrome without serious adverse events Pathogenetic Mechanisms Implicated in Sjögren's
Description
Here are some of the side effects you should know about.

Your provider will explain the mechanism, potential effects, side effects, and alternatives during consultation
Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." Nutritionists help us decode that message.

Learn about the health benefits and potential risks of these popular diabetes and weight loss medications.

This comes after a judge rejected a bid by these pharmacies to keep selling the mixture.

In recent years, medications like semaglutide, commonly used for type 2 diabetes and weight management, have gained widespread attention
